ADVANCED PANCREATIC CANCER
Clinical trials for ADVANCED PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for pancreatic cancer: experimental combo targets tough tumors
Disease control Not yet recruitingThis phase 2 study tests whether adding a hedgehog inhibitor (NLM-001) and two immunotherapy drugs (botensilimab and balstilimab) to standard chemotherapy can shrink tumors better than chemotherapy alone in people with advanced pancreatic cancer that hasn't been treated yet. Abou…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Nelum Corp • Aim: Disease control
Last updated May 26, 2026 07:35 UTC
-
New hope for pancreatic cancer: phase 3 trial launches
Disease control Not yet recruitingThis study tests a new drug called MRG004A for people with advanced pancreatic cancer that has not responded to standard treatments. About 231 participants will receive either MRG004A plus best supportive care or a placebo plus best supportive care. The goal is to see if the drug…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE3 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 07:30 UTC